The effectiveness of once-daily subcutaneous liraglutide administration for weight loss management in adults was established in five large-scale randomized multicentre phase 3 trials [49,50,51,52,53], four of which were part of the SCALE program (Satiety and Clinical AdiposityLiraglutide Evidence in nondiabetic and diabetic individuals), leading to its approval at a dose of 3.0 mg subcutaneous once-daily (weekly increased from 0.6 mg to 3 mg/day)
Prioritize whole foods, including lean proteins, vegetables, and fiber
Frequently Asked Questions Medical weight loss programs may include FDA-approved medications such as semaglutide , tirzepatide, phentermine, or a combination like naltrexone/bupropion
There are a few key underlying principles
In December 2025, a separate multidistrict litigation grouping was created under the same federal judge for lawsuits alleging vision injuries
Ozempic, along with other GLP-1 weight loss medications, is primarily used to manage blood sugar levels in individuals with type 2 diabetes